Narrative review / 2017
Intermittent and periodic fasting show efficacy for weight loss, improved insulin resistance, and reduced cardiovascular disease risk factors in humans.
This review examines intermittent fasting (IF), periodic fasting (PF), and time-restricted feeding (TRF) in animal models and human subjects. In normal and overweight humans, studies of IF, PF, and TRF have shown efficacy for weight loss and improvements in health indicators, including insulin resistance and cardiovascular risk factors. The underlying mechanisms involve cellular stress response pathways that enhance mitochondrial health, DNA repair, autophagy, and stem cell-based regeneration. The authors state that randomized controlled clinical trials comparing IF, PF, and continuous energy restriction are needed to establish efficacy in disease prevention and management.
- Study type
- Narrative review
- Who was studied
- Normal and overweight human subjects and laboratory animal models
- What was measured
- Weight loss, insulin resistance, cardiovascular risk factors, and cellular stress responses
THE PAPER
Impact of intermittent fasting on health and disease processes.
Mattson MP, Longo VD, Harvie M. Ageing Res Rev, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.